Literature DB >> 2646075

Pulmonary manifestations in Behçet's syndrome.

I Raz1, E Okon, T Chajek-Shaul.   

Abstract

Among 72 patients with Behçet's syndrome, seven had pulmonary vascular involvement. Additional data from 42 cases in the literature are discussed. Recurrent episodes of dyspnea, cough, chest pain, and hemoptysis were the primary clinical signs, mainly in young men, appearing 3.6 years after the first manifestation of Behçet's syndrome. Fever, elevated ESR, and anemia were common, and chest x-ray films showed pulmonary infiltrates, pleural effusions, and prominent pulmonary arteries. Ventilation-perfusion scans showed perfusion defects even when chest x-ray films were normal. Pulmonary artery aneurysms were seen in 7/13 in whom angiography was done. Of 42 patients, 16 died, 15 from fatal pulmonary hemorrhage, 80 percent within two years from the development of pulmonary disease. Histopathologic study results showed vasculitis of pulmonary vessels of various sizes, leading to thrombosis, destruction of the elastic laminae, aneurysms, and arteriobronchial fistula. In addition, pulmonary emboli and the aphthous lesion of the tracheobronchial tree may aid the clinical picture. Anticoagulant therapy may be hazardous in patients with aneurysmal dilatation of the pulmonary vascular tree, and the beneficial effect of corticosteroid therapy is discussed. Pulmonary vasculitis in Behçet's syndrome is a unique clinical and pathologic picture, differing from other vasculitides affecting the lung, presents a major threat to the patient's life.

Entities:  

Mesh:

Year:  1989        PMID: 2646075     DOI: 10.1378/chest.95.3.585

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  20 in total

Review 1.  Pulmonary manifestations of Behçet's disease.

Authors:  F Erkan; A Gül; E Tasali
Journal:  Thorax       Date:  2001-07       Impact factor: 9.139

Review 2.  Imaging of the pulmonary manifestations of systemic disease.

Authors:  A G Rockall; D Rickards; P J Shaw
Journal:  Postgrad Med J       Date:  2001-10       Impact factor: 2.401

3.  Life threatening chylous pleural and pericardial effusion in a patient with Behçet's syndrome.

Authors:  L Cöplü; S Emrí; Z T Selçuk; F Kalyoncu; F Balkanci; A A Sahín; Y I Bariş
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

Review 4.  Behçet's disease.

Authors:  T Inoue; K Satake
Journal:  Gastroenterol Jpn       Date:  1991-10

Review 5.  Pulmonary vasculitis: classification, clinical features, and management.

Authors:  A Ciaccia; M Ferrari; F M Facchini; G Caramori; L Fabbri
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

6.  Cyclosporin treatment in rapidly progressive pulmonary thromboembolic Behçet's disease.

Authors:  J F Vansteenkiste; P Peene; J A Verschakelen; K P van de Woestijne
Journal:  Thorax       Date:  1990-04       Impact factor: 9.139

7.  Transcatheter embolotherapy of pulmonary artery aneurysms as emergency treatment of hemoptysis in Behcet patients: experience of a referral center and a review of the literature.

Authors:  Guillaume Voiriot; Antoine Parrot; Martine Antoine; Aude Gibelin; Samuel Haddad; Marie-France Carette; Muriel Fartoukh; Antoine Khalil
Journal:  Intern Emerg Med       Date:  2018-03-07       Impact factor: 3.397

8.  Life-threatening right ventricular thrombosis in association with phospholipid antibodies.

Authors:  S O'Hickey; C Skinner; J Beattie
Journal:  Br Heart J       Date:  1993-09

9.  Major vascular involvement in Behçet's disease: a retrospective study of 796 patients.

Authors:  Yunyun Fei; Xuemei Li; Sen Lin; Xiaojun Song; Qingjun Wu; Yanlin Zhu; Xin Gao; Wen Zhang; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang
Journal:  Clin Rheumatol       Date:  2013-02-27       Impact factor: 2.980

10.  Pulmonary artery aneurysms in Behçet's disease.

Authors:  Sema Yilmaz; Kadriye Akar Cimen
Journal:  Rheumatol Int       Date:  2009-08-20       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.